A pharmacokinetics and pharmacodynamics equivalence trial of proposed pegfilgrastim biosimilar, MYL-1401H vs EU-Neulasta® and US-Neulasta®. (February 2017) - Waller, C.; Tiessen, R.; Lawrence, T.; Shaw, A.; Liu, M.; Sharma, R.; Baczkowski, M.; Kothekar, M.; Dias, R.; Barve, A.; Pennella, E.